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ABSTRACT.  The underlying mechanism of the unusual emissive behavior of [Re(CO)3-1,1-
bisthiazole-(1,4)-diaminobutane)] bromide (4-BT) has been investigated.  Synthesis and 
spectroscopic characterization of structurally similar isomers ([Re(CO)3-1,1-bis-2-thiazole-(1,4)-
diaminobutane)] bromide (2-BT) and , location of triplet states, solid state and low temperature 
spectroscopic measurements, and DFT calculations show that the photophysical properties are 
not due to photoisomerization as previously hypothesized.  The results show that the unusual 
emissive behavior is not observed in structural isomers, is specific to the previously reported 
complex, 4-BT, and may arise from vibrational energy relaxation and vibrational cooling. 
Translation of the unusual emissive behavior to the solid state offers an interesting platform 







 Luminescent transition metal complexes incorporating chromophoric conjugated ligands 
have received considerable contemporary attention because of their attractive photophysical 
properties1,2 and their potential applications as probes, sensors and photonic devices.3 The 
useful properties of such materials include long luminescence lifetimes, large Stokes shifts and 
resistance to photobleaching.1,4,5 
 
 Within this general area of luminescent transition metal compounds, those containing 
the rhenium tricarbonyl core, {Re(CO)3}+, have been extensively explored because of their 
intrinsically attractive photophysical and biological properties.6-29  While the photophysical 
characteristics of these complexes have been described in terms of the excited states: metal-to-
ligand charge transfer (MLCT), ligand-to-ligand charge transfer (LLCT), and intraligand (IL) 
states, the MLCT character predominates.  The most extensively studied class of rhenium 
tricarbonyl compounds are the [ReI(CO)3(LL)X] complexes, where LL is a bidentate diimine 
ligand or two monodentate pyridyl ligands and X is a halogen, alkyl group or nitrogen donor 
ligand. 
 
 The [Re(CO)3(LL)X] compounds have been shown to be effective for elucidating the 
various excited state properties.  The complexes are robust, and incorporation of different X-
ligands is facile.  The systematic tuning of the electronic properties of the complexes is readily 
achieved by varying the substituents on the diimine ligand.  The emission from these complexes 
generally occurs from triplet metal-to-ligand charge transfer (3MLCT) excited state, as a result 
of rapid vibrational relaxation and intersystem crossing from higher vibrational energy levels.  
As a result, the identity of the lowest energy -acceptor ligands is an important determinant in 
the photophysical properties.  Such complexes can be highly emissive (em = 0.001-0.1) and 
often display long lifetimes (10 ns to 1s) in solution due to the triplet MLCT. 
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 A particularly attractive application of the luminescence properties of {Re(CO)3}+1-core 
complexes is the potential to combine and contrast data from complementary imaging 
techniques such as the correlation of nuclear and fluorescence imaging to relate deep-tissue 
whole-body imaging with histopathology and fluorescence microscopy to provide insights into 
mechanisms of binding, selectivity and cellular distribution of targeted radiopharmaceuticals. 
In this respect, over the past decade we have introduced and developed a novel approach for 
the preparation of labeled peptides, exploiting the coordination chemistry of the M(CO)3+ core 
and amino acid based bifunctional chelates.  The design of these bifunctional single amino acid 
chelates (SAAC) exploits the modification of a natural or synthetic amino acid to incorporate a 
tridentate terminus and a terminus for attachment to small peptides at variable positions 
within the backbone (Scheme 1).30-64 A useful feature of the SAAC approach is the ability to 
prepare luminescent probes based on the Re(CO)3+ core, allowing the design of complementary 
pairs of fluorescent and radioactive probes.  This in vitro/in vivo pairing allows the assessment 
of the fate of the imaging agent at the cellular level in real time and the evaluation of 
mechanisms relevant to cellular localization and specificity.37, 65-67   
 



















 In the course of these studies, we became interested in the site-specific delivery of 
pharmaceuticals via the vitamin B12 (B12) uptake pathway,68,69 an observation that encouraged 
us to extend our imaging studies to the intrinsic factor (IF) B12 ileum anchored receptor, 
cubilin,70,71 which mediates endocytotic uptake of the IF complex of B12 to the blood.  The 
expression of cubilin in select tissues such as placental membranes, gall bladder and the GI tract 
make it a potential target for selective delivery of cytotoxic or imaging agents.  This transport 
mechanism should facilitate entry of a rhenium fluorescent probe tethered to B12.  The complex 
B12-BQBA-Re(CO)3+ was prepared (BQBA = tert-butyl 4-(bis- ((quinolin-2-
yl)methyl)amino)butylcarbamate), and confocal microscopy showed internalization and 
accumulation of the metallated bioconjugate bound to IF in the nuclear and cytosolic region of 
the placental BeWo cell line, confirming the key role of cubilin receptor in the internalization of 
[B12-BQBA-Re(CO)3+-IF].59 
 Despite this success, the B12-BQBA-Re(CO)3+ probe had certain deficiencies, such as 
water insolubility, weak fluorescence and difficulty in distinguishing probe signal from 
background.  To overcome these difficulties, we prepared the B12-BTBA-Re(CO)3+ (BTBA = N,N-
bis(thiazole-methyl) aminobutylamine}), where the bisquinoline ligand was replaced by a 
bisthiazole ligand (Scheme 2).63  [B12-BTBA-Re(CO)3+-IF] complex is internalized in A549 cells 
with clear cytoplasmic localization. 
 
Scheme 2.  (a) The prototypical SAAC ligand, N,N-bis-(2-pyridyomethyl) lysine, BPLys; (b) and (c) 





























 In addition to these observations, it was noted that the probe displayed novel dual 
excitation/emission properties that aided in its use in cell studies through dual excitation.  
Detailed photophysical studies of the non-conjugated 4-BT complex alone revealed unusual 
behavior with emission wavelength varying with excitation wavelength far more than 
associated with the dual emission originally /observed exploited in the B12 conjugate imaging 
work. The experimental and DFT computational studies supported the assignment of the most 
intense absorption bands of the electronic spectrum to ligand based -* and d-* 3MLCT58 and 
their associated emission bands.  However, it was also noted that there were also weaker bands 
at lower energy that gave rise to emission at lower wavelengths than those observed from 
excitation of the stronger bands.  Since there is no observed energy transfer from the ligand 
based and MLCT excited species, different species must be involved.  Our theoretical studies1 
suggested that the emission variation with input variation observed for 4-BT is a consequence 
either of vibrational energy relaxation (VER) (including intramolecular vibrational energy 
redistribution (IVR) and vibrational cooling (VC) and/or photoinduced isomerization to a 
mixture of linkage isomers with discrete emission characteristics and electronic states. In any 
case, this represents a rare example of violation of the Kasha-Vavilov Rule (on the timescales 
studied) that emission occurs from the lowest energy excited state of the same multiplicity.72-76 
 In order to test the hypothesis that the unusual luminescence behavior of 4-BT is a 
consequence of isomerization to a mixture of linkage isomers, the isomeric ligands of Scheme 3 
were prepared and their complexes with the {Re(CO)3}1+ core investigated.  The results of this 
study indicate that photoinduced linkage isomerization is most likely not the explanation for 






Scheme 3.  The ligands of this study: (a) 4-BTBA is {N,N-bis(4-thiazole-methyl) 




Materials and Methods 
All chemicals, reagents, and solvents were purchased from Sigma-Aldrich, Combi-Blocks Inc., 
Acros Organic, Matrix Scientific or Fisher Scientific. Purifications were performed using an 
Agilent 1200 reverse-phase High-Performance Liquid Chromatography (HPLC) with an 
automated fraction collector and an Eclipse C18 XBD column (4.6mm x 150mm x 5μm), or an 
Agilent 1100 reverse-phase HPLC using an Eclipse C18 XBD analytical column (4.6mm x 150mm x 
5μm). All samples were purified at a flow rate of 1.0 mL·min-1 with a UV detection of 254nm. 
1H-NMR spectroscopy was performed using a Bruker Advance DPX 400 MHz spectrometer or a 
Bruker DPX 300 spectrometer. Mass spectroscopy was performed using a Shimadzu 8040 
electrospray-mass spectrometer (LCMS) or a Bruker AutoFlex III Matrix Assisted Laser 
Desorption/Ionization-Time of Flight (MALDI-TOF) mass spectrometer. Fluorescent 
measurements were conducted with a PTI Quantamaster Steady State Spectrofluorimeter , 
while bubbling argon and oxygen, or submerged in liquid nitrogen. 
Syntheses 
Synthesis of ligands  
The ligands were prepared using a modified procedure based on those previously described in 




























mmol) in DCM (100 mL) was added the appropriate aldehyde (22 mmol).  After the mixture was 
stirred for 10 min, NaBH(OAc)3 (22 mmol) was added and the mixture was stirred overnight at 
room temperature under N2. The mixture was diluted with DCM (100 mL) and washed with 
saturated sodium bicarbonate (100 mL), water (2 × 100 mL), and brine (100 mL). The organic 
layer was dried over sodium sulfate and concentrated to afford the crude product. The crude 
material was purified by combiflash using EtOAc in hexane to provide tert-butyl (4-(bis(thiazol-
4-ylmethyl)amino)butyl)carbamate (1a) and tert-butyl (2-(bis(thiazol-4-ylmethyl)amino)butyl) 
carbamate (1b).  Deprotection was accomplished by addition of 4M HCl in dioxane (5 mL) to a 
solution compound 1(a) or 1(b) (2 mmol) in DCM (10 mL) at room temperature followed by 
stirring for 3h. A solid was formed during the course of the reaction which was filtered, washed 
with DCM (5 mL) and used without further purification in the next step. 
 
tert-butyl (4-(bis(thiazol-4-ylmethyl)amino)butyl)carbamate (1a): 1H NMR (500 MHz, CDCl3) δ 
8.77 (d, J = 2.2 Hz, 2H), 7.27 (s, 2H), 4.96 (s, 1H), 3.88 (s, 4H), 3.08 (d, J = 6.8 Hz, 2H), 2.55 (t, J = 
7.2 Hz, 2H), 1.60 (t, J = 7.5 Hz, 2H), 1.48 (t, J = 7.3 Hz, 2H), 1.42 (s, 9H).13C NMR (126 MHz, CDCl3) 
δ 156.08, 155.37, 152.52, 115.83, 78.93, 53.43, 53.30, 40.27, 28.51, 27.71, 24.50. Yield: 56%. 
1,1-bis-4-thiazole-(1,4)-diaminobutaneHCl (4-BTBAHCl): 1H NMR (500 MHz, CD3OD) δ 9.17 – 
9.08 (m, 2H), 8.04 – 7.94 (m, 2H), 4.59 (s, 4H), 3.24 – 3.19 (m, 2H), 2.96 (t, J = 7.7 Hz, 2H), 2.04 – 
1.92 (m, 2H), 1.74 – 1.59 (m, 2H).13C NMR (126 MHz, CD3OD) δ 157.06, 146.29, 124.85, 53.79, 
51.99, 39.99, 25.54, 22.21.  Yield: 90%. 
tert-butyl (4-(bis(thiazol-2-ylmethyl)amino)butyl)carbamate (1b):1H NMR (500 MHz, CDCl3) δ 
7.71 (d, J = 3.3 Hz, 2H), 7.30 (d, J = 3.3 Hz, 2H), 4.58 (s, 1H), 4.06 (s, 4H), 3.08 (t, J = 6.7 Hz, 2H), 
2.65 (t, J = 7.1 Hz, 2H), 1.64 – 1.56 (m, 2H), 1.51 (q, J = 7.3 Hz, 2H), 1.42 (s, 9H).13C NMR (126 
MHz, CDCl3) δ 170.92, 156.33, 142.87, 120.00, 79.49, 56.04, 54.04, 40.67, 28.80, 27.98, 24.85.  
Yield: 61%. 
1,1-bis-2-thiazole-(1,4)-diaminobutaneHCl (2-BTBAHCl): 1H NMR (500 MHz, CD3OD) δ 8.01 (d, 
J = 3.4 Hz, 2H), 7.85 (d, J = 3.4 Hz, 2H), 4.83 (s, 4H), 3.32 – 3.29 (m, 2H), 2.97 (t, J = 7.7 Hz, 2H), 
1.94 (ddd, J = 10.9, 6.3, 2.8 Hz, 2H), 1.72 (q, J = 7.9 Hz, 2H).13C NMR (126 MHz, CD3OD) δ 142.94, 
124.37, 54.98, 53.44, 40.12, 25.66, 23.00.  Yield: 92%. 
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tert-butyl (4-(bis(thiazol-5-ylmethyl)amino)butyl)carbamate (1c): 1H NMR (500 MHz, CDCl3) δ 
8.76 (s, 2H), 7.71 (s, 2H), 4.55 (s, 1H), 3.83 (s, 4H), 3.09 (d, J = 6.8 Hz, 2H), 2.51 (s, 2H), 1.61 – 
1.51 (m, 2H), 1.50 – 1.45 (m, 2H), 1.43 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 156.10, 153.61, 
153.57, 141.84, 136.93, 79.28, 52.69, 49.24, 40.44, 28.55, 27.86, 24.48.MS (ESI+): m/z calcd for 
C17H26N4S2O2 [M + H], found 283.5. 
1,1-bis-5-thiazolemethyl-(1,4)-diaminobutaneHCl (5-BTBAHCl): 1H NMR (500 MHz, CD3OD) δ 
9.79 (s, 2H), 8.49 (s, 2H), 4.78 (s, 4H), 3.17 (d, J = 8.7 Hz, 2H), 3.01 (t, J = 7.6 Hz, 2H), 1.96 (td, J = 
7.3, 6.2, 3.4 Hz, 2H), 1.73 (t, J = 7.8 Hz, 2H). 13C NMR (126 MHz, DMSO-d6) δ 158.12, 147.15, 




[Re(CO)5]Br was purchased from Sigma-Aldrich and used without further purification.  
[Re(CO)5]Br 10 g, 0.03 mol) was placed in a 250 mL round-bottom flask, distilled H2O (100 ml) 
added and the reaction heated to reflux for 24 h. Periodic rinsing of the reflux condenser 
washed unreacted [Re(CO)5]Br from the condenser into the reaction solution. The crude 
mixture was cooled to room temperature and filtered through a plug of Celite to remove small 
amounts of particulate impurities. Subsequently, the solution was concentrated under vacuum 
to give the desired product as a light green powder in nearly quantitative yield. IR (MeOH, 
 cm-1): 2025, 1941 ((C=O) for fac{Re(CO)3}+1 group). MS (ESI+): m/z calcd for C3H6O6Re [M –Br] 
321.3, found 321.2.  
 
General procedure for the syntheses of Re complexes  
 Equimolar concentrations of [Re(H2O)3(CO)3]Br and the selected ligand analogue were 
refluxed in methanol at 65⁰C for 3 hours. Final products were allowed to cool and concentrated 
under vacuum.  The crude products were dissolved in pure water and purified via HPLC. 
Gradients started at 95% 0.1% TFA in H2O (Solvent A), 5% methanol (Solvent B). The gradient 
was held at 5% Solvent B for 2 min and increased to 40% Solvent B over 1 min where it was held 
at 40% for 8 minutes. 
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Representative Synthesis of [Re(CO)3-1,1-bisthiazole-(1,4)-diaminobutane)] bromide (4-BT) 
Re(CO)3(H2O)3Br (420 mg, 1.04 mmol), and 1,1-bisthiazole-1,4-diaminobutane (294 mg, 1.04 
mmol) were refluxed in MeOH at >65 °C for 3 h. The solvent was reduced under vacuum and 
dissolved in 10% MeOH, 10% dimethyl sulfoxide (DMSO) (v/v) in H2O. 4-BT was purified by 
reverse-phase HPLC with a gradient of 95% 0.1 % TFA in H2O and 5% MeCN increased to 12% 
MeCN over 7 min, then increased to 20% MeCN over 2 min, and finally increased to 25% MeCN 
over 5 minutes. The complex was characterized using MALDI-ToF MS (Shimadzu LCMS-4080) 
using a 10 mg/mL alpha-cyano-4-hydroxycinnamic acid (CHCA) matrix, dissolved in 50:50 
mixture of H2O:MeCN with 0.1% formic acid; 4-BT was also characterized using 1H-NMR in 
DMSO-d6. Further characterization was done by EAS and fluorescence spectroscopy. Yield is 5% 
at >99+% purity based on HPLC. 1H-NMR (500 MHz) D2O: δ = 10.43 (d, 2H), δ = 8.61 (s, 2H), δ = 
5.50 (m, 4H), δ = 3.82 (t, 2H), δ = 3.51 (t, 2H), δ = 2.82 (d, 2H), δ = 2.57 (t, 2H).  HRMS (ESI+), calc 
for C15H18N4O3S2Re 552.66, found 552.66.  HPLC (UV, 254 nm): Rt = 5.2 min. 
Crystals of [Re(CO)3-1,1-bis-2-thiazolemethyl-1-aminobutylammonium)] bromidehydrobromide  
(2-BTHBr) for x-ray diffraction were grown by dissolving 50 mg of the complex in 5 mL of hot 
methanol in a flask equipped with a reflux condenser.  The temperature was slowly lowered 
from 64 C to room temperature over a period of 4 h, whereupon blocks of 2-BTHBr were 
observed to crystallize from solution. 
[Re(CO)3-1,1-bis-2-thiazolemethyl-(1,4)-diaminobutane)] bromide (2-BT):   1H-NMR (400 MHz) 
D2O: δ = 7.82 (d, 2H), δ = 7.61 (d, 2H), δ = 4.96 (t, 4H), δ = 3.96 (t, 2H), δ = 3.12 (t, 2H), δ = 1.98 
(m, 2H), δ = 1.78 (m, 2H).  HRMS (ESI+), calc for C15H18N4O3S2Re 552.66, found 552.66. HPLC 
(UV, 254 nm): Rt = 4.7 min.  Crystals were grown by slow evaporation from methanol. 
Attempted synthesis of [Re(CO)3-1,1-bis-5-thiazolemethyl-(1,4)-diaminobutane)] bromide (5-BT):   
Several attempts were made to prepare this isomer: (1) refluxing the ligand with 
Re(CO)3(H2O)3Br in methanol for up to 48h, (2) refluxing the ligand with Re(CO)3(H2O)3Br in 
various solvents including acetonitrile, DMF and water/ethanol mixtures for 6, 24 and 48h, (3) 
refluxing the ligand with Re(CO)5Br in the solvents noted above for several time periods, and (4) 
solvatothermal syntheses in acetonitrile at 100 C for 24 to 72h.  These attempts invariably 
yielded the unreacted starting materials. 
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Attempted Synthesis of [Re(CO)3-1,1-bis-5-thiazolemethyl-(1,4)-diaminobutane] bromide (5-BT). 
(a) The procedure adopted for the preparation of 4-BT was used.  The starting unreacted 
materials were recovered after 3 to 24 h of reflux.  (b) Syntheses in ethanol, DMF and 
acetonitrile were also unsuccessful.  (c) Solvatothermal synthesis in various water/acetonitrile 
mixtures failed to produce the ligand bound product. 
 
Air, Argon, Oxygen atmosphere Spectroscopic Measurements 
4-BT was dissolved in EPA (ethanol:isopentane:ethyl ether 2:5:5) emission profiles were 
collected in an air atmosphere originally with excitation at 280 and 488 nm. Argon was then 
bubbled through the solution for 15 minutes and emission scans were recollected. Oxygen was 
then bubbled through the solution for 15 minutes and emission scans were recollected. 
 
77K Spectroscopic Measurements 
 4-BT was dissolved in EPA and placed in a specially made cuvette submerged in liquid 
nitrogen. Excitation scans were performed at 400, 450, 470, 490, and 500 nm. Emission scans 
were performed at 315 nm. 
 2-BT was dissolved in EPA and placed in a specially made cuvette submerged in liquid 
nitrogen. Emission scans were performed with excitation at 240, 250, 260, and 270 nm. 
 
Solid state fluorescent measurements  
 A solution of the sample is prepared by adding <0.5 ml of solvent (DCM or MeCN, 
depending on solubility) and agitating until the sample dissolves. Subsequently, a drop of this 
solution is introduced into a cuvette with a narrow aperture for a stopper, which is laid on its 
side and slowly tilted until the solution has covered the bottom face of the cuvette as it lies. A 
gentle stream of nitrogen is played over the solution through a flexible tube until it has 
evaporated. This procedure is repeated until these is a visible film on the glass, which is then 
place in the spectrometer with the cuvette holder rotated so that the face of the cuvette with 
the film is angled to face both the excitation slits and the detection slits (but not at 45 degrees 
to directly reflect the excitation beam into the detector).   
 11 
X-Ray Crystallography.  
Only low quality crystals of the Re complexes could be grown, despite numerous attempts in a 
variety of solvents (methanol, DMF, acetonitrile, methylene chloride) and solvent mixtures 
under different conditions of temperature and concentration.  In all instances, the crystals 
proved to be twinned.  Crystallographic data for 2-BTHBr were collected on a Bruker KAPPA 
APEX DUO diffractometer using Mo-Kα radiation (λ = 0.71073Å) containing an APEX II CCD 
system. 77 All data collections were taken at low temperature (90K).  The data were corrected 
for Lorentz and polarization effects,78 and adsorption corrections were made using SADABS.79 
The structure was solved by direct methods.  Refinements for each structure were carried out 
using the SHELXTL crystallographic software.80  Following assigning all non-hydrogen atoms, the 
models were refined against F2 first using isotropic and then using anisotropic thermal 
displacement parameters.  The hydrogen atoms were introduced in calculated positions and 
then refined isotropically.  Neutral atom scattering coefficients along with anomalous 
dispersion corrections were taken from the International Tables, Vol. C.  Images of the crystal 
structures were generated using CrystalMaker®.81 Full tables of bond lengths and angles for the 
structures are given in the Supplementary materials.  Summary of crystallographic details for 
the structure of 2-BTHBr: C15H19Br2N4O3S2Re, fw = 713.48, orthorhombic Pnnm, a = 27.550(3) 
Å, b = 8.479(1) Å, c = 12.52591) Å, V = 2925.6(1) Å3, Z = 4,  = 7.04 mm-1, Dcalc = 1.620 g cm-1, 
R1 = 0.1048, wR2 = 0.3128 for 1377 reflections with Fo  4(Fo).  CCDC    contains the 
supplementary crystallographic data for the structures of 2-BTHBr. These data can be 
obtained free of charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html, or from the 
Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: (+44) 
1223-336-033; or e-mail: deposit@ccdc.cam.ac.uk. 
 
 
Results and Discussion 
Syntheses and Structures of Compounds 
The ligands were prepared in good yield according to a modified version of previously reported 





                                                                                   1(a,b)                                            2-BT, 4-BT 
                                              i) R-CHO, NaBH(OAc)3, DCM, r.t, 12h ii) 4M Dioxane-HCl, r.t, 3h 
Scheme 4. Synthesis of ligands. 
 
 The complexes 2-BT and 4-BT were prepared by reaction of the appropriate ligand with 
Re(CO)3(H2O)3Br in methanol.  2_BT was crystallized by slow evaporation from methanol 
solution.  However, 2-BT could only be crystallized by slowly ramping down the temperature of 
a methanol solution from the boiling point to room temperature.  The crystalline material was 
subsequently shown to be the hydrobromide salt 2-BTHBr.  Despite repeated attempts, even 
under forcing solvatothermal conditions, the complex incorporating the 1,1-bis-5-thiazole-(1,4)-
diaminobutane ligand, i.e., [Re(CO)3-1,1-bis-5-thiazolemethyl-(1,4)-diaminobutane)]Br (5-BT), 
could not be prepared.  This observation is consistent with the extensive literature on the 
coordination chemistry of thiazole ligands with transition metals which provides no examples of 
coordination through the sulfur. 
 As shown in Figure 1, the x-ray structural studies confirm that 2-BTHBr exhibits the 
chemically robust fac-{Re(CO)3}+ core and distorted octahedral geometries with the remaining 
coordination sites occupied by the amine nitrogen donor and the nitrogen atoms of the thiazole 
ligands.  No evidence for sulfur coordination is observed as anticipated from previous 
studies.35,82-86  The Re-carbonyl distances, Re-C of 1.948(32) Å, are consistent with those 
described for similar complexes.35,87 The Re-amine distance of 2.348(27) Å, is somewhat longer 
than the Re-thiazole nitrogen distances of 2.099(22) Å, consistent with sp3 and sp2 
hybridization, respectively.  The most significant distortions from idealized octahedral 
geometries are the amine nitrogen-Re-thiazole nitrogen angles which result from the formation 
of strained five-membered chelate rings.  The cation of the crystal structure is present as the +2 
species [Re(CO)3{(C3H2SNCH2)2N(CH2)4NH3}]+2 as a consequence of protonation of the amine 
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terminus of the ligand.  Charge compensation for the di-cationic 
[Re(CO)3{(C3H2SNCH2)2N(CH2)4NH3}]+2 is provided by two uncoordinated Br- anions (see 
Supplementary materials Figure S ).  
 
Spectroscopic Studies 
In our previous study, we also reported that the Re(CO)3-1,1-bis-4-thiazole-(1,4)- 
diaminobutane complex [Re(CO)3{(C3H2NSCH2)2N(CH2)4NH2}]
+ (4-BT) exhibited variability of the 
emission maximum with excitation wavelength (see Supplementary Figure S1) with a marked, 
and non-linear, red shift of the emission maximum associated with the progressive lengthening 
of excitation wavelength.  This behavior persisted in different solvents, showing changes in the 
emission maximum with excitation wavelength, which were generally red- shifted, as expected 
as a more polar solvent stabilized the more polar excited states associated especially with 
charge-separated species.  Furthermore, the emission maxima were found to shift at different 
rates as a function of the excitation wavelengths, as shown by the slope of the curve in a plot of 
maximum emission wavelength as a function of excitation wavelength (Figure 1). 
 
Figure 1.  Variation of emission maximum of 4-BT with excitation wavelength in MeOH.  
 Both experimental and computational studies support the assignment of the most 
intense absorption bands observed in the electronic absorption spectra as being of ligand-
based –* and d–* 1MLCT nature, and their associated emission bands.  However, there 
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were weaker broad absorption bands at lower energy, which give rise to emission at lower 
wavelengths than those observed from excitation of the normal bands. The lack of observed 
energy transfer from the ligand based and MLCT excited species to the lower energy emissions 
implies different species are involved.  The preliminary theoretical studies suggested that 
photo-isomerisation of 4-BT to a mixture of coordination isomers with discrete emission 
characteristics and electronic structures gave rise to the observed emission characteristics.  This 
speculation would require the existence of N,S- and/or S,S-isomers of the 4-BT complex 
(Scheme 5).  To investigate this possibility, several studies, focusing on structural, DFT, solution 























































Low temperature studies (77 K) on 2-BT and 4-BT 
Spectroscopic studies were performed on 4-BT and 2-BT at 77K in liquid nitrogen. Upon 
excitation at 315 nm at 77K, the single emission band observed at room temperature for 4-BT 
now exhibits multiple emission bands (Figure 3, inset). Excitation scans of 4-BT were conducted 
at 400, 450, 470, 490, and 500 nm at 77K.  The excitation scans of 4-BT at 400 nm shows major 
contributions from approximately 300 nm, and as the excitation increases the contributions 
from approximately 250 and 300 nm are inversely proportional, suggesting that there are 
multiple emissive states accessible to the complex. Emission profiles for 2-BT (Figure 4) at both 
room temperature and 77K show no difference in profile or number of emissive bands, an 
observation consistent with Kasha’s rule.  Thus, the behavior of 2-BT is quite different from that 
observed for 4-BT, suggesting that the unusual luminescence characteristics of 4-BT are unique 
to that isomer. 
 
 
Figure 3. Excitation scans for 4-BT at 77K in EPA. Inset: emission scan with excitation at 315 nm 













Figure 4. Top: Emission scan for 2-BT at room temperature in EPA. Bottom: Emission scans for 
2-BT at 77K in EPA. 
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Investigation of triplet state in Air, O2  or  inert atmosphere (Argon) 
Characterization of a triplet state can be accomplished by changing the amount of gas present 
in the solvent. Oxygen is a known triplet state quencher and will decrease emission when 
introduced to a solution containing the complex of interest. Emission profiles of 4-BT, where a 
triplet state is anticipated for excitation at 488 nm, were collected under ambient conditions, 
prior to introducing argon or oxygen and subsequently after introducing argon and oxygen. The 
emission profile at this wavelength remains unchanged, suggesting that the emission does not 
arise from a triplet state (Figure 5). The same experiments were conducted with excitation at 
280 nm (Figure 6), which clearly demonstrate decrease in emission under O2 and an increase in 
emission under Ar.  These observations are consistent with 4-BT accessing a triplet state upon 
excitation at 280 nm, rather than the expected singlet state, possibly arising from the ligand 







Figure 5. Emission scan for 4-BT at room temperature under air (blue), argon (red) and oxygen 








Solid State Studies 
In the 3D fluorescence spectroscopy experiments the relative emission intensity of the give 
code number was recorded between 400 and 500 nm for a series of excitation wavelengths 
from 310 to 360 nm in 5 nm increments. The relative emission intensities are presented in two 
formats, in Figure 7 as a pseudo 3D topographical image, and in Figure 8 as a 2D grid of 
excitation vs. emission wavelength with a coloured contour presentation of the emission 
intensity. A sample which shows a single emission maximum and a single excitation maximum 
will appear to have a single summit in Figure 7 and one high intensity feature highlighted by the 
coloured contours in Figure 8, which is clearly not the case. Close examination of Figure 8 
shows that while the most intense emission is always around 450-500 nm this appears to be 
originating from two different excitation mechanisms (i.e. electronic transitions), one with 
maximum efficiency around 315 nm and one with maximum efficiency around 335 nm, with a 
minimum around 325 nm seen as a valley between the two peaks. These features may also 
arise from different emission mechanisms. Additionally, there is an additional feature with 
maximum emission intensity around 450 nm, which is most efficiently excited around 330 nm, 
and barely at all at 315 nm, clearly showing it is of different origin to the 450-500 nm emission 
bands. Thus Figures 7 and 8 clearly illustrate that the sample is displaying a range of different 
emission behaviours, dependent upon the excitation wavelength, which is best interpreted in 
Figure 6: Emission scan for 4-BT at room temperature under air (blue), argon 
(green) and oxygen atmospheres (red) at 280 nm in EPA. 
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terms of a failure for all of the excited states to relax to a single emissive state regardless of 




Figure 7.  A pseudo 3D topographical image of the 3D fluorescence spectroscopy showing the 
relative emission intensity of 4-BT for a series of excitation wavelengths from 310 to 360 nm in 




Figure 8.  The relative emission intensities of 4-BT shown as a 2D grid of excitation vs. emission 
wavelength with a coloured contour presentation of the emission intensity. 
 
In support of the now predicted outcomes for 4-BT being driven, not by photo-induced 
isomerism, but rather access a triplet state via VER, we always performed DFT focusing on 
calculating the excited emission states for 2-BT and 4-BT.   
 
DFT Calculations 
The electronic structures of both 2-BT and 4-BT were simulated using the Gaussian09 density 
functional theory software package.88 The calculations were performed using the Becke 3-
parameter Lee-Yang-Parr (B3LYP) hybrid functional89 and the electrons were modelled using 
the def2-SVP basis set.90 The simulations were performed using the PCM solvent model using 
methanol as the solvent.91 The absorption spectra were simulated using the time dependent-
DFT (TD-DFT) framework.92   
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Given the similarities in the structures of the two systems, it is not surprising that the simulated 
electronic structures are equally similar. However, when the predicted transitions were 
investigated, there was a clear difference between the orbitals involved in the electronic 
transitions between the two molecules. In the case of 2-BT, the strongest and lowest energy 
transitions primarily involve the HOMO and HOMO-2 → LUMO and LUMO+2 orbitals, which 
represents a clear MLCT-type of transition. However, in the case of 4-BT there is a significant 
contribution from the HOMO-3 → LUMO transition, which represents a LMCT transition. It is 
important to note that the HOMO → LUMO and LUMO+2 transitions are also observed in 4-BT. 
Therefore, there is a significantly more of a contribution from the ligands in the case of 4-BT 
compared to 2-BT, which might give rise to the observed electronic behaviour.  
 
Figure 9. Relevant orbitals to the absorption process in the two studied BT derivatives. The top 
two molecules are 2-BT, while the lower two are 4-BT. It is important to note that the orbitals 















1 HOMO LUMO,+2 319.02 3279.69 





      
4-BT 










Table 1: First three electronic transitions in the studied systems, with the occupied and 
unoccupied orbitals listed, the corresponding transition wavelength, and the maximum molar 
extinction coefficient at the resonant energy.   
 
Conclusions 
We have successfully (new synthesis(yields)/structures/DFT/solution +solid state photophysical 
measurements) that now provide a clearer understanding of what is highly unusual photo-
induced emissive behavior for a Re(I) complex (4-BT). Compared to the isomer 2-BT, 4-BT 
possesses multiple emissive states which are present upon cooling to 77K. The location of the 
triplet state in 4-BT is also unusual and present below 500 nm, a region where singlet states 
from coordinated ligands would be expected to dominate. Solid state experiments and 
comparisons of 4-BT to the isomer 2-BT suggest that the previously reported hypothesis for the 
origin of the behavior of 4-BT, structural isomerization upon excitation, is not the case. The 2-
BT structure would be more energetically favorable to form a Re-S bond upon excitation and a 
ring flip as there is not the extra carbon spacer that is present in 4-BT. The energy level needed 
to produce a structural isomer without the presence of solvent would be considerably greater.  
The observation that the 5-thiazole based ligand, 1,1-bis-5-thiazole-(1,4)-diaminobutane, which 
is designed to allow coordination only through the sulfur donors, does not provide the 
analogous [Re(CO)3-1,1-bis-5-thiazole-(1,4)-diaminobutane)]Br (5-BT), even under the most 
forcing conditions, supports this conclusion.  Since the behavior of 4-BT also carries over to the 
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solid state, it is likely that 4-BT is unique in its ability to emit from multiple states dependent 
upon excitation. 
Since the results of this study indicate that photoinduced isomerization to a mixture of linkage 
isomers with discrete emission characteristics and electronic states is not the cause of the 
emission variation with input variation observed for 4-BT, an alternative hypothesis must be 
proposed and tested.  Consequently, the observed behavior may arise as a consequence of 
vibrational energy relaxation (VER) (including intramolecular vibrational energy redistribution 
(IVR) and vibrational cooling (VC)).  However, this is not a trivial task due to the complicated 
excited-state potential energy surfaces (PES) of these complexes and multiple photoinduced 
energy relaxation processes with different timescales following photoexcitation. Ultrafast laser 
spectroscopy techniques with sub-picosecond temporal resolution are capable of providing 
quantitative and quantum-state-resolved information of the PESs and energy relaxation 
dynamics that can elucidate at the molecular level mechanisms that govern photophysical 
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This excitation scan at 570 nm shows that contributions are from across the whole absorption. 
This suggest that this is our lowest excited stated however the lifetime (5ns) and the low 








                                          
             
             
             
             
             
             
             
             
             
             
             
     
